Aurora Cannabis Looks To Make $3 Billion Merger With CanniMed Therapeutics

Look out, Canopy Growth Corporation. Your reign as the pure-play marijuana stock with the highest market cap might not last for long.

On Tuesday, Aurora Cannabis announced that it had submitted a proposal to acquire all shares of another Canadian marijuana grower, CanniMed Therapeutics. Aurora is offering to buy CanniMed, which trades on the Toronto Stock Exchange, for $24 per share. Continue reading “Aurora Cannabis Looks To Make $3 Billion Merger With CanniMed Therapeutics”